| Gretchen Price, MA, CCC-SLP | |
|
1175 Beverly Pike, Elkins, WV 26241-9759 | |
| (304) 636-1391 | |
| (304) 636-1371 |
| Full Name | Gretchen Price |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1175 Beverly Pike, Elkins, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275805947 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-1559 (West Virginia) | Primary |
| Provider Name | Wv Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063692333 PECOS PAC ID: 8123106416 Enrollment ID: O20080428000417 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, home health, hospice care and assisted living companies, today reported record results for the second quarter of 2010.
A new study published in the Lancet journal EClinicalMedicine suggests that more mosquito nets are likely needed between mass campaigns to keep malaria cases in check.
AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%
A new Harris Interactive/HealthDay poll finds that reducing unemployment and creating new jobs are clearly considered the top immediate priorities for President Obama and Congress, but healthcare reform is still important. Half of U.S. adults say it will be a "bad thing" if there is no major reform of the healthcare system in the next two years.
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gretchen Price, MA, CCC-SLP 1175 Beverly Pike, Elkins, WV 26241-9759 Ph: (304) 636-1391 | Gretchen Price, MA, CCC-SLP 1175 Beverly Pike, Elkins, WV 26241-9759 Ph: (304) 636-1391 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, home health, hospice care and assisted living companies, today reported record results for the second quarter of 2010.
A new study published in the Lancet journal EClinicalMedicine suggests that more mosquito nets are likely needed between mass campaigns to keep malaria cases in check.
AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%
A new Harris Interactive/HealthDay poll finds that reducing unemployment and creating new jobs are clearly considered the top immediate priorities for President Obama and Congress, but healthcare reform is still important. Half of U.S. adults say it will be a "bad thing" if there is no major reform of the healthcare system in the next two years.
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.
› Verified 7 days ago
Tara L. Troastle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 812 Gorman Ave, Elkins, WV 26241 Phone: 304-636-3300 Fax: 304-637-3441 | |
Susanna J Halliday, CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 812 Gorman Avenue, Elkins, WV 26241 Phone: 304-636-3300 | |
Lori Marie Dibacco, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 11th St, Elkins, WV 26241 Phone: 304-624-6554 Fax: 304-624-5223 | |
Stephanie Lynn Zickefoose, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 11th St, Elkins, WV 26241 Phone: 304-624-6554 Fax: 304-624-5223 | |
Miss Beth Ann Childers, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 11th St, Elkins, WV 26241 Phone: 304-636-9188 Fax: 304-636-9188 | |
Mrs. Ingrid Backus, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 11th St, Elkins, WV 26241 Phone: 304-636-9150 |